Take two individuals, A and B.
A is maligned baseball star Alex Rodriguez.
Not really.
Consequently, Person B pursues the controversial advantage conferred by "neuroenhancement" medications.
Regardless of the outcomes that these medications achieve, the motivations of their consumers are the same.
Whether doping for physical or cognitive enhancement, both parties are using medications with indeterminate efficacy and risk to obtain an advantage.
A pharmacologically derived professional advantage in the office should not be seen as more appropriate than a similar advantage gained in a stadium.